Staging & Imaging for Pancreatic SC-NEC

Staging is the process of determining the size of the tumor and whether it has spread to other parts of the body. For Pancreatic Small Cell Neuroendocrine Carcinoma (SC-NEC), staging is an urgent and intensive process because this cancer can grow and move quickly ^[1][2].

Because SC-NEC is so rare, your doctors must also ensure that the cancer actually started in the pancreas and is not a “secondary” cancer that spread there from another organ, most commonly the lungs ^[3][4].

The Foundation: Anatomic Imaging

Anatomic scans look at the physical structure of your organs. They are the first step in mapping out the cancer.

• Pancreatic-Protocol CT: This is a specialized CT scan that takes images at very specific times after contrast dye is injected. It provides the most detailed look at the pancreas itself and its relationship to nearby major blood vessels ^[1][5].
• Liver MRI: If your CT scan shows possible spots on the liver, an MRI—specifically one using diffusion-weighted imaging (DWI)—is often the best tool to see if they are cancerous. Doctors may also use a special “hepatobiliary” contrast dye to get the clearest possible picture of liver involvement ^[5][6].

Functional Imaging: Seeing Tumor Activity

Functional scans (PET scans) look at what the cells are doing rather than just what they look like. In SC-NEC, the “activity” of the tumor is a vital clue for your care team.

FDG-PET/CT: The “Standard” for SC-NEC

An FDG-PET scan uses a radioactive sugar (glucose) tracer. Because SC-NEC cells divide rapidly, they “eat” a lot of sugar, causing them to light up brightly on this scan ^[7][8].

• Why it’s used: This scan may be recommended to identify high-grade, aggressive disease ^[7].
• Limitations: Inflammation and infection can also cause areas to light up (a false-positive), so results must be interpreted carefully in clinical context ^[7][9].

DOTATATE-PET: The “Receptor” Scan

You may also hear about a Gallium-68 DOTATATE or Copper-64 DOTATATE PET scan. These scans look for somatostatin receptors on the surface of neuroendocrine cells.

• The SC-NEC Difference: While these scans are the “gold standard” for slow-growing (well-differentiated) neuroendocrine tumors, they are often less helpful for SC-NEC. As these tumors become more aggressive, they often lose these receptors ^[1][7].
• Why doctors order it anyway: Sometimes, doctors order both to get a fuller picture of the cancer’s “biology,” or to rule out a well-differentiated component. However, the absence of uptake on a DOTATATE scan does not definitively prove a tumor is NEC ^[7][10].

Ruling Out the Lungs

One of the most critical steps in staging pancreatic small cell cancer is looking at the lungs. Small Cell Lung Cancer (SCLC) is much more common than the pancreatic version and is known to spread to the pancreas ^[11].

To be certain your cancer is “Primary Pancreatic SC-NEC,” your team will typically perform:

1. Chest CT: A high-resolution scan of the chest to look for a primary lung mass ^[3].
2. Clinical Correlation: Integrating imaging like whole-body FDG-PET to evaluate for disease elsewhere ^[12].

Staging Systems

While most pancreatic cancers are staged using the TNM system (Tumor, Node, Metastasis), SC-NEC is unique. Treatment decisions often depend on whether the disease is:

• Localized: Contained within the pancreas, which may permit multimodality treatment ^[13].
• Locally Advanced: Spread to nearby major blood vessels.
• Metastatic: Spread to distant organs like the liver, lungs, or bones ^[13].

Most patients with SC-NEC are diagnosed at the metastatic stage, which is why treatment usually begins with systemic (whole-body) chemotherapy ^[13].